Concepedia

Vernon E. Steele

VE

Statistics

Publications

194

Citations

11.7K

H-Index

56

Active since

1976

Affiliations

National Cancer Institute(Current)

University of Oklahoma Health Sciences Center

University of Genoa

The Ohio State University

University of Alabama at Birmingham

Vernon E. Steele is an author at National Cancer Institute specializing in medicine, oncology, and pharmacology.

Publications per year

1976–2019

194

Publications

194

Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.

Toshihiko Kawamori, R Lubet, Vernon E. Steele et al. · PubMed · 1999 · 592 citations

Medicine, Oncology, Pharmacology +14

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

Bandaru S. Reddy, Yoshinobu Hirose, Ronald A. Lubet et al. · PubMed · 2000 · 463 citations

Medicine, Oncology, Pharmacology +13

Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke

Alberto Izzotti, George A. Calin, Patrizio Arrigo et al. · The FASEB Journal · 2008 · 435 citations · Full text

Life Sciences, Molecular Biology, Toxicology +15

Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.

Chinthalapally V. Rao, Abraham Rivenson, Barbara Simi et al. · PubMed · 1995 · 404 citations

Medicine, Oncology, Pharmacology +16

Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.

Hanan S. Samaha, Gary J. Kelloff, Vernon E. Steele et al. · PubMed · 1997 · 297 citations

Medicine, Oncology, Pharmacology +17

1–5 of 194